JPRN-UMIN000019262已完成未知
Examination about the efficacy and safety of abatacept iv in rheumatoid arthritis - Examination for effectiveness with the intervention time of abatacept therapy in rheumatoid arthritis.(ORIB study)
适应症
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 入组人数
- 30
研究概览
简要总结
Rammission Rate at week 48 (as follow) DAS28ESR 34.5% SDAI 34.5% High disease activity patients got more efficacy response by abatacept therapy than others.
研究设计
- 研究类型
- Observational
入排标准
- 年龄范围
- 20years-old 至 ot applicable（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •patients with no MTX treatment past biological agents' user
研究者
相似试验
已完成
1 期
Assessment of the Safety of ABT-308 in Healthy Volunteers and Subjects With AsthmaAsthmaNCT00986037AbbVie47
已完成
3 期
A Year 2, Safety Extension Study of the Combination of ABT-335 and Statin Therapy for Subjects With Mixed DyslipidemiaMixed DyslipidemiaNCT00491530Abbott310
已完成
3 期
A 52-Week Parallel Group Safety Study of TD-4208 in Chronic Obstructive Pulmonary Disease (COPD)Chronic Obstructive Pulmonary Disease (COPD)NCT02518139Mylan Inc.1,060
已完成
3 期
A Study to Evaluate the Safety and Efficacy of ABT-493/ABT-530 in Adult Post-Liver or Post-Renal Transplant Recipients With Chronic Hepatitis C Virus (MAGELLAN-2)Chronic Hepatitis CHCVHepatitis C VirusNCT02692703AbbVie100
已完成
1 期
A Multiple Dose Study of Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of ABT-288 in Stable Subjects With SchizophreniaSchizophreniaNCT00888693AbbVie81